Searchable abstracts of presentations at key conferences in endocrinology

ea0063p1074 | Pituitary and Neuroendocrinology 3 | ECE2019

Local myofascitis: an unusual adverse reaction to lanreotide autogel injections

Hage Mirella , Marin Cristi , Bakopoulou Sophia , Marcellus Capucine De , Guyot Alexis , Gaillard Stephan , Raffin-Sanson Marie Laure , Cazabat Laure

Background: Somatostatin analogues are the mainstay medical treatment of acromegaly. Side effect of this treatment includes gastrointestinal disturbances, cholelithiasis, and local reactions at injection sites. Herein we report an unusual case of local myofascitis after one-year treatment with deep subcutaneous injections of lanreotide Autogel in a patient with acromegalo-gigantism.Clinical case: A 25-year-old man was found to have an invasive macroadeno...

ea0063oc13.5 | Anterior and Posterior pituitary 2 | ECE2019

Pan-genomic classification of pituitary adenomas

Neou Mario , Villa Chiara , Armignacco Roberta , Jouinot Anne , Septier Amandine , Raffin-Sanson Marie-Laure , Perlemoine Karine , Bernier Michele , Baussart Bertrand , Bertherat Jerome , Gaillard Stephan , Assie Guillaume

Pituitary adenomas, now called pituitary neuroendocrine tumors (PitNETs), vary in histological type, secretion, invasion and growth speed. A World Health Organization (WHO) histo-prognostic classification was released in 2017. Pituitary tumorigenesis is largely unexplained. Rare germline mutations (MENIN, AIP), and common somatic mutations in somatotroph (GNAS) and corticotroph (USP8) are reported. Recently, genomic analyses have been report...

ea0063gp243 | Anterior and Posterior Pituitary | ECE2019

Histological classification of pituitary neuroendocrine tumors: genomic insights on cell lineage

Villa Chiara , Neou Mario , Armignacco Roberta , Jouinot Anne , Septier Amandine , Perlemoine Karine , Bernier Michele , Laure Raffin-Sanson Marie , Baussart Bertrand , Bertherat Jerome , Gaillard Stephan , Assie Guillaume

The 2017 World Health Organization (WHO) classification of pituitary adenomas is based on cell lineage and transcription factors (TFs). Pituitary progenitors expressing Pit-1 are driven towards the somato-lacto-thyrotroph differentiation, T-Pit towards corticotroph, and SF-1 towards gonadotroph. We recently generated a multi-genomic classification of pituitary neuroendocrine tumors (PitNETs) (abstract submitted to ECE2019 by Neou M.). Transcriptome classification identified si...

ea0090oc7.4 | Oral Communications 7: Pituitary and Neuroendocrinology 2 | ECE2023

Lysine demethylase KDM1A and ectopic expression of GIP-receptor in somatotropinomas of patients with paradoxical response to oral glucose

Chasseloup Fanny , Tosca Lucie , Regazzo Daniela , Proust Alexis , Hage Mirella , Kuhn Emmanuelle , Jublanc Christel , Mokhtari Karima , Salenave Sylvie , Gaillard Stephan , Parker Fabrice , Boch Anne-Laure , Tachdjian Gerard , Chanson Philippe , Bouligand Jerome , Occhi Gianluca , Kamenicky Peter

Introduction: Paradoxical increase of GH following oral glucose load has been described in ~30% of patients with acromegaly and has been related to the ectopic expression of the glucose-dependent insulinotropic polypeptide (GIP) receptor (GIPR) in somatotropinomas. Recently, we identified germline pathogenic variants of lysine demethylase 1A (KDM1A) in patients with GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing’s syndrome. Patients...

ea0093oc24 | Oral communication 4: Pituitary and Neuroendocrinology | EYES2023

Transcriptome in paraffin samples for the diagnosis and prognosis of pituitary neuroendocrine tumors (PITNETS)

Benanteur Nesrine , Villa Chiara , Birtolo Maria Francesca , Jouinot Anne , De Murat Daniel , Letourneur Franck , Gaillard Stephan , Raffin-Sanson Marie-Laure , Emile Jean-Francois , Bertherat Jerome , Baussard Bertrand , Assie Guillaume

An initial multi-omics analysis of PitNETs has refined histological classifications, and could improve diagnostic and prognostic assessment (Neou, Cancer Cell 2020). Of all omics, transcriptome best discriminates between these different classes. This molecular classification has been built upon frozen samples, which are difficult to use in routine clinical practice.Aim: Demonstrate the feasibility of measuring the transcriptome in Formalin-Fixed Paraffin...

ea0022p383 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience

Raverot Gerald , Sturm Nathalie , De Fraipont Florence , Caron Philippe , Muller Marie , Cortet-Rudelli Christine , Salenave Sylvie , Assaker Richard , Dufour Henry , Gaillard Stephan , Francois Patrick , Jouanneau Emmanuel , Bernier Michele , Figarella-Branger Dominique , Maurage Claude-Alain , Trouillas Jacqueline , Borson-Chazot Francoise , Brue Thierry

Context: To date ten publications reporting only 16 patients with pituitary aggressive tumors or carcinomas treated with temozolomide are available. Expression of O6-methylguanine-DNA-methyltranferase (MGMT), a DNA repair protein implicated in the resistance to temozolomide, was studied in only 10 out of these 16 patients. It has been suggested that low expression of MGMT could predict temozolomide efficacy.Objective: The aim of this st...